These guidance’s are based on current Good Distribution Practices (GDP) for importers and providers of the distribution of active substances for human use. Active substances are defined as that or a mixture of substances that are intended to be used in the manufacture of a medicinal product. An active substance will become the active ingredient of that product
Distribution consists of the activities consisting of Procuring, importing, holding, supplying or exporting of the actives. Intermediates are not covered in this presentation.